Mar
07
2017
In Kuwait was launched the Heberprot-P for diabetic foot
Kuwait, March 7, 2017. The Heberprot-P Cuban product for the treatment of diabetic foot, recently registered in Kuwait, was launched by the Center for Genetic Engineering and Biotechnology (CIGB) in coordination with the Central Gulf Medical Company Company at the Hotel Mövenpick of this capital.
